JW-2286

N/A

Report date: 2024/12/25 14:54:26
NME

Base Information

Drug NameJW-2286
Drug Alias NameST-2286JW2286JW-2286
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsSolid tumoursStomach NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesC&C Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesJw Pharmaceutical CorpC&C Research Laboratories
Inactive CompaniesN/A
Active IndicationsSolid tumoursStomach NeoplasmsColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A